Last 12 months
Inside the activity.
1 purchase rows · 8 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 1 |
| Dec 2025 | 0 | 3 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 2 |
| Mar 2026 | 1 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 1 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 1 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 15, 2025 Filed Aug 15, 2025 21:18 UTC | SaleCommon Stock | 11,000 | $259.29 | $2,852,158.10 |
DisclosureSEC source: 0001225208-25-007301 · doc4.xml · nonDerivative · entry 5 Gokey Timothy C · CIK 0001296187 · CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 154,634.0271 F2 · kind: The reported transaction is an open market sale pursuant to a 10b5-1 plan adopted by the reporting person May 14, 2025. F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $257.12 - $260.53, inclusive. The reporting person undertakes to provide to Broadridge Financial Solutions, Inc., any shareholder of Broadridge Financial Solutions, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (5) to this Form 4. Read SEC document |
|
| August 14, 2025 Filed Aug 15, 2025 21:18 UTC | Exercise / conversionStock Option (Right to Buy) · Derivative | 99,831 | $0.00 Strike: $98.31 | $0.00 |
DisclosureSEC source: 0001225208-25-007301 · doc4.xml · derivative · entry 7 Gokey Timothy C · CIK 0001296187 · CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 99,831 shares Expires 2029-02-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The reported transaction is a stock option exercise pursuant to a 10b5-1 plan adopted by the reporting person on May 14, 2025. Read SEC document |
|
| August 14, 2025 Filed Aug 15, 2025 21:18 UTC | SaleCommon Stock | 84,571 | $259.53 | $21,948,677.80 |
DisclosureSEC source: 0001225208-25-007301 · doc4.xml · nonDerivative · entry 4 Gokey Timothy C · CIK 0001296187 · CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 165,634.0271 F2 · kind: The reported transaction is an open market sale pursuant to a 10b5-1 plan adopted by the reporting person May 14, 2025. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $258.72 - $260.73, inclusive. The reporting person undertakes to provide to Broadridge Financial Solutions, Inc., any shareholder of Broadridge Financial Solutions, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (4) to this Form 4. Read SEC document |
|
| August 14, 2025 Filed Aug 15, 2025 21:18 UTC | Exercise / conversionCommon Stock | 99,831 | $98.31 | $9,814,385.61 |
DisclosureSEC source: 0001225208-25-007301 · doc4.xml · nonDerivative · entry 3 Gokey Timothy C · CIK 0001296187 · CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 250,205.0271 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The reported transaction is a stock option exercise pursuant to a 10b5-1 plan adopted by the reporting person on May 14, 2025. Read SEC document |
|
| August 13, 2025 Filed Aug 15, 2025 21:18 UTC | Exercise / conversionStock Option (Right to Buy) · Derivative | 46,561 | $93.88 Strike: $93.88 | $4,371,146.68 |
DisclosureSEC source: 0001225208-25-007301 · doc4.xml · derivative · entry 6 Gokey Timothy C · CIK 0001296187 · CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 46,561 shares Expires 2028-02-12 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The reported transaction is a stock option exercise pursuant to a 10b5-1 plan adopted by the reporting person on May 14, 2025. Read SEC document |
|
| August 13, 2025 Filed Aug 15, 2025 21:18 UTC | SaleCommon Stock | 39,251 | $262.46 | $10,301,629.06 |
DisclosureSEC source: 0001225208-25-007301 · doc4.xml · nonDerivative · entry 2 Gokey Timothy C · CIK 0001296187 · CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 150,374.0271 F2 · kind: The reported transaction is an open market sale pursuant to a 10b5-1 plan adopted by the reporting person May 14, 2025. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $261.4100 - $263.9900, inclusive. The reporting person undertakes to provide to Broadridge Financial Solutions, Inc., any shareholder of Broadridge Financial Solutions, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (3) to this Form 4. Read SEC document |
|
| August 13, 2025 Filed Aug 15, 2025 21:18 UTC | Exercise / conversionCommon Stock | 46,561 | $93.88 | $4,371,146.68 |
DisclosureSEC source: 0001225208-25-007301 · doc4.xml · nonDerivative · entry 1 Gokey Timothy C · CIK 0001296187 · CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 189,625.0271 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The reported transaction is a stock option exercise pursuant to a 10b5-1 plan adopted by the reporting person on May 14, 2025. Read SEC document |
|
| August 12, 2025 Filed Aug 12, 2025 20:20 UTC |
PERRY CHRISTOPHER JOHNPresident
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 7,480 | $0.00 Strike: $198.30 | $0.00 |
DisclosureSEC source: 0001225208-25-007206 · doc4.xml · derivative · entry 3 PERRY CHRISTOPHER JOHN · CIK 0001619128 · President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 22,441 Underlying: Common Stock · 7,480 shares Expires 2034-02-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 12, 2025 Filed Aug 12, 2025 20:20 UTC |
PERRY CHRISTOPHER JOHNPresident
|
SaleCommon Stock | 7,036 | $262.72 | $1,848,493.70 |
DisclosureSEC source: 0001225208-25-007206 · doc4.xml · nonDerivative · entry 2 PERRY CHRISTOPHER JOHN · CIK 0001619128 · President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 48,812.521 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $262.150 - $263-185, inclusive. The reporting person undertakes to provide to Broadridge Financial Solutions, Inc., any shareholder of Broadridge Financial Solutions, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (1) to this Form 4. Read SEC document |
| August 12, 2025 Filed Aug 12, 2025 20:20 UTC |
PERRY CHRISTOPHER JOHNPresident
|
Exercise / conversionCommon Stock | 7,480 | $198.30 | $1,483,284.00 |
DisclosureSEC source: 0001225208-25-007206 · doc4.xml · nonDerivative · entry 1 PERRY CHRISTOPHER JOHN · CIK 0001619128 · President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 55,848.521 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 02, 2025 Filed Jul 3, 2025 16:17 UTC |
Duelks Robert NDirector
|
GrantCommon Stock | 75 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-25-006465 · doc4.xml · nonDerivative · entry 1 Duelks Robert N · CIK 0001477044 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,933 F1 · shares: The reported transaction reflects the award of additional Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the payment of Broadridge's regular quarterly dividend on the common stock underlying the Deferred Stock Units previously issued. This amount represents a like number of shares of Broadridge common stock. The Deferred Stock Units vest in full upon grant and will settle in shares of Broadridge common stock upon the director's separation from service with Broadridge. Read SEC document |
| July 02, 2025 Filed Jul 3, 2025 16:17 UTC |
FLOWERS MELVIN LDirector
|
GrantCommon Stock | 8 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-25-006466 · doc4.xml · nonDerivative · entry 1 FLOWERS MELVIN L · CIK 0001196490 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,181 F1 · shares: The reported transaction reflects the award of additional Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the payment of Broadridge's regular quarterly dividend on the common stock underlying the Deferred Stock Units previously issued. This amount represents a like number of shares of Broadridge common stock. The Deferred Stock Units vest in full upon grant and will settle in shares of Broadridge common stock upon the director's separation from service with Broadridge. Read SEC document |
| July 02, 2025 Filed Jul 3, 2025 16:17 UTC |
keller brettDirector
|
GrantCommon Stock | 14 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-25-006467 · doc4.xml · nonDerivative · entry 2 keller brett · CIK 0001214608 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,885 F2 · shares: The reported transaction reflects the award of additional Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the payment of Broadridge's regular quarterly dividend on the common stock underlying the Deferred Stock Units previously issued in lieu of cash compensation under the Director Deferred Compensation Program (the "DCUs"). This amount represents a like number of shares of Broadridge common stock. The DCUs vest in full upon grant and will settle in shares of Broadridge common stock commencing with the director's separation from service with Broadridge. Read SEC document |
| July 02, 2025 Filed Jul 3, 2025 16:17 UTC |
keller brettDirector
|
GrantCommon Stock | 31 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-25-006467 · doc4.xml · nonDerivative · entry 1 keller brett · CIK 0001214608 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,871 F1 · shares: The reported transaction reflects the award of additional Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the payment of Broadridge's regular quarterly dividend on the common stock underlying the Deferred Stock Units previously issued. This amount represents a like number of shares of Broadridge common stock. The Deferred Stock Units vest in full upon grant and will settle in shares of Broadridge common stock upon the director's separation from service with Broadridge. Read SEC document |
| July 02, 2025 Filed Jul 3, 2025 16:17 UTC |
MURRAY EILEEN KDirector
|
GrantCommon Stock | 6 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-25-006469 · doc4.xml · nonDerivative · entry 2 MURRAY EILEEN K · CIK 0001341752 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,525 F2 · shares: The reported transaction reflects the award of additional Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the payment of Broadridge's regular quarterly dividend on the common stock underlying the Deferred Stock Units previously issued. This amount represents a like number of shares of Broadridge common stock. The Deferred Stock Units vest in full upon grant and will settle in shares of Broadridge common stock upon the director's separation from service with Broadridge. Read SEC document |
| July 02, 2025 Filed Jul 3, 2025 16:17 UTC |
MURRAY EILEEN KDirector
|
GrantCommon Stock | 6 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-25-006469 · doc4.xml · nonDerivative · entry 1 MURRAY EILEEN K · CIK 0001341752 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,531 F1 · shares: The reported transaction reflects the award of additional Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the payment of Broadridge's regular quarterly dividend on the common stock underlying the Deferred Stock Units previously issued in lieu of cash compensation under the Director Deferred Compensation Program (the "DCUs"). This amount represents a like number of shares of Broadridge common stock. The DCUs vest in full upon grant and will settle in shares of Broadridge common stock commencing with the director's separation from service with Broadridge. Read SEC document |
| July 02, 2025 Filed Jul 3, 2025 16:17 UTC |
Zavery AmitDirector
|
GrantCommon Stock | 12 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-25-006471 · doc4.xml · nonDerivative · entry 2 Zavery Amit · CIK 0001781064 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,732 F2 · shares: The reported transaction reflects the award of additional Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the payment of Broadridge's regular quarterly dividend on the common stock underlying the Deferred Stock Units previously issued. This amount represents a like number of shares of Broadridge common stock. The Deferred Stock Units vest in full upon grant and will settle in shares of Broadridge common stock upon the director's separation from service with Broadridge. Read SEC document |
| July 02, 2025 Filed Jul 3, 2025 16:17 UTC |
Zavery AmitDirector
|
GrantCommon Stock | 15 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-25-006471 · doc4.xml · nonDerivative · entry 1 Zavery Amit · CIK 0001781064 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,720 F1 · shares: The reported transaction reflects the award of additional Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the payment of Broadridge's regular quarterly dividend on the common stock underlying the Deferred Stock Units previously issued in lieu of cash compensation under the Director Deferred Compensation Program (the "DCUs"). This amount represents a like number of shares of Broadridge common stock. The DCUs vest in full upon grant and will settle in shares of Broadridge common stock commencing with the director's separation from service with Broadridge. Read SEC document |
| July 02, 2025 Filed Jul 3, 2025 16:17 UTC |
Nazareth Annette L.Director
|
GrantCommon Stock | 8 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-25-006470 · doc4.xml · nonDerivative · entry 2 Nazareth Annette L. · CIK 0001846828 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,388 F2 · shares: The reported transaction reflects the award of additional Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the payment of Broadridge's regular quarterly dividend on the common stock underlying the Deferred Stock Units previously issued. This amount represents a like number of shares of Broadridge common stock. The Deferred Stock Units vest in full upon grant and will settle in shares of Broadridge common stock upon the director's separation from service with Broadridge. Read SEC document |
| July 02, 2025 Filed Jul 3, 2025 16:17 UTC |
Nazareth Annette L.Director
|
GrantCommon Stock | 9 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-25-006470 · doc4.xml · nonDerivative · entry 1 Nazareth Annette L. · CIK 0001846828 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,380 F1 · shares: The reported transaction reflects the award of additional Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the payment of Broadridge's regular quarterly dividend on the common stock underlying the Deferred Stock Units previously issued in lieu of cash compensation under the Director Deferred Compensation Program (the "DCUs"). This amount represents a like number of shares of Broadridge common stock. The DCUs vest in full upon grant and will settle in shares of Broadridge common stock commencing with the director's separation from service with Broadridge. Read SEC document |
| July 02, 2025 Filed Jul 3, 2025 16:17 UTC |
Markus Maura A.Director
|
GrantCommon Stock | 16 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-25-006468 · doc4.xml · nonDerivative · entry 2 Markus Maura A. · CIK 0001571545 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 31,105.102 F2 · shares: The reported transaction reflects the award of additional Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the payment of Broadridge's regular quarterly dividend on the common stock underlying the Deferred Stock Units previously issued in lieu of cash compensation under the Director Deferred Compensation Program (the "DCUs"). This amount represents a like number of shares of Broadridge common stock. The DCUs vest in full upon grant and will settle in shares of Broadridge common stock commencing with the director's separation from service with Broadridge. Read SEC document |
| July 02, 2025 Filed Jul 3, 2025 16:17 UTC |
Markus Maura A.Director
|
GrantCommon Stock | 51 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-25-006468 · doc4.xml · nonDerivative · entry 1 Markus Maura A. · CIK 0001571545 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 31,089.102 F1 · shares: The reported transaction reflects the award of additional Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the payment of Broadridge's regular quarterly dividend on the common stock underlying the Deferred Stock Units previously issued. This amount represents a like number of shares of Broadridge common stock. The Deferred Stock Units vest in full upon grant and will settle in shares of Broadridge common stock upon the director's separation from service with Broadridge. Read SEC document |
| July 02, 2025 Filed Jul 3, 2025 16:17 UTC |
Carter Pamela LDirector
|
GrantCommon Stock | 19 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-25-006464 · doc4.xml · nonDerivative · entry 1 Carter Pamela L · CIK 0001396958 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,261 F1 · shares: The reported transaction reflects the award of additional Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the payment of Broadridge's regular quarterly dividend on the common stock underlying the Deferred Stock Units previously issued. This amount represents a like number of shares of Broadridge common stock. The Deferred Stock Units vest in full upon grant and will settle in shares of Broadridge common stock upon the director's separation from service with Broadridge. Read SEC document |
| June 12, 2025 Filed Jun 13, 2025 16:12 UTC |
keller brettDirector
|
GrantCommon Stock | 130 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-25-005930 · doc4.xml · nonDerivative · entry 1 keller brett · CIK 0001214608 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,840 F1 · shares: The reported transaction reflects the grant of Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the director's deferral of cash compensation under the Director Deferred Compensation Program and represents a like number of shares of Broadridge common stock (the "DCUs"). The DCUs vest in full upon grant and will settle in shares of Broadridge common stock commencing with the director's separation from service with Broadridge. Read SEC document |
| June 12, 2025 Filed Jun 13, 2025 16:12 UTC |
MURRAY EILEEN KDirector
|
GrantCommon Stock | 180 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-25-005932 · doc4.xml · nonDerivative · entry 1 MURRAY EILEEN K · CIK 0001341752 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,519 F1 · shares: The reported transaction reflects the grant of Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the director's deferral of cash compensation under the Director Deferred Compensation Program and represents a like number of shares of Broadridge common stock (the "DCUs"). The DCUs vest in full upon grant and will settle in shares of Broadridge common stock commencing with the director's separation from service with Broadridge. Read SEC document |
| June 12, 2025 Filed Jun 13, 2025 16:12 UTC |
Zavery AmitDirector
|
GrantCommon Stock | 130 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-25-005934 · doc4.xml · nonDerivative · entry 1 Zavery Amit · CIK 0001781064 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,705 F1 · shares: The reported transaction reflects the grant of Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the director's deferral of cash compensation under the Director Deferred Compensation Program and represents a like number of shares of Broadridge common stock (the "DCUs"). The DCUs vest in full upon grant and will settle in shares of Broadridge common stock commencing with the director's separation from service with Broadridge. Read SEC document |
| June 12, 2025 Filed Jun 13, 2025 16:12 UTC |
Nazareth Annette L.Director
|
GrantCommon Stock | 130 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-25-005933 · doc4.xml · nonDerivative · entry 1 Nazareth Annette L. · CIK 0001846828 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,371 F1 · shares: The reported transaction reflects the grant of Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the director's deferral of cash compensation under the Director Deferred Compensation Program and represents a like number of shares of Broadridge common stock (the "DCUs"). The DCUs vest in full upon grant and will settle in shares of Broadridge common stock commencing with the director's separation from service with Broadridge. Read SEC document |
| June 12, 2025 Filed Jun 13, 2025 16:12 UTC |
Markus Maura A.Director
|
GrantCommon Stock | 146 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-25-005931 · doc4.xml · nonDerivative · entry 1 Markus Maura A. · CIK 0001571545 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 31,038.102 F1 · shares: The reported transaction reflects the grant of Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the director's deferral of cash compensation under the Director Deferred Compensation Program and represents a like number of shares of Broadridge common stock (the "DCUs"). The DCUs vest in full upon grant and will settle in shares of Broadridge common stock commencing with the director's separation from service with Broadridge. Read SEC document |
| June 06, 2025 Filed Jun 6, 2025 18:29 UTC |
Duelks Robert NDirector
|
SaleCommon Stock | 500 | $245.15 | $122,574.75 |
DisclosureSEC source: 0001225208-25-005752 · doc4.xml · nonDerivative · entry 1 Duelks Robert N · CIK 0001477044 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,858 Read SEC document |
| June 06, 2025 Filed Jun 6, 2025 18:34 UTC |
DESCHUTTER DOUGLAS RICHARDCo-President ICS
|
SaleCommon Stock | 4,903 | $245.76 | $1,204,966.18 |
DisclosureSEC source: 0001225208-25-005753 · doc4.xml · nonDerivative · entry 1 DESCHUTTER DOUGLAS RICHARD · CIK 0001391093 · Co-President ICS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,263.8948 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $245.40 - $246.13, inclusive. The reporting person undertakes to provide to Broadridge Financial Solutions, Inc., any shareholder of Broadridge Financial Solutions, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (1) to this Form 4. Read SEC document |
| June 06, 2025 Filed Jul 28, 2025 21:08 UTC Amendment |
Duelks Robert NDirector
|
SaleCommon Stock | 500 | $245.15 | $122,574.75 |
DisclosureSEC source: 0001225208-25-006811 · doc4a.xml · nonDerivative · entry 1 Duelks Robert N · CIK 0001477044 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · Robert N. Duelks 2007 Revocable Trust Disclosed balance after: 8,853 Read SEC document |
| June 04, 2025 Filed Jun 5, 2025 14:35 UTC |
Markus Maura A.Director
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 5,771 | $0.00 Strike: $56.37 | $0.00 |
DisclosureSEC source: 0001225208-25-005725 · doc4.xml · derivative · entry 3 Markus Maura A. · CIK 0001571545 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,771 shares Expires 2025-11-12 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 04, 2025 Filed Jun 5, 2025 14:35 UTC |
Markus Maura A.Director
|
SaleCommon Stock | 3,556 | $243.08 | $864,408.48 |
DisclosureSEC source: 0001225208-25-005725 · doc4.xml · nonDerivative · entry 2 Markus Maura A. · CIK 0001571545 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,892.102 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $242.91 - $243.38, inclusive. The reporting person undertakes to provide to Broadridge Financial Solutions, Inc., any shareholder of Broadridge Financial Solutions, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (1) to this Form 4. Read SEC document |
| June 04, 2025 Filed Jun 5, 2025 14:35 UTC |
Markus Maura A.Director
|
Exercise / conversionCommon Stock | 5,771 | $56.37 | $325,311.27 |
DisclosureSEC source: 0001225208-25-005725 · doc4.xml · nonDerivative · entry 1 Markus Maura A. · CIK 0001571545 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 34,448.102 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 27, 2025 Filed May 28, 2025 15:54 UTC |
DESCHUTTER DOUGLAS RICHARDCo-President ICS
|
SaleCommon Stock | 5,056 | $239.55 | $1,211,161.26 |
DisclosureSEC source: 0001225208-25-005483 · doc4.xml · nonDerivative · entry 1 DESCHUTTER DOUGLAS RICHARD · CIK 0001391093 · Co-President ICS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,166.8948 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $239.4450 - $239.6950, inclusive. The reporting person undertakes to provide to Broadridge Financial Solutions, Inc., any shareholder of Broadridge Financial Solutions, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (1) to this Form 4. Read SEC document |
| May 20, 2025 Filed May 20, 2025 15:38 UTC |
Carter Pamela LDirector
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 4,107 | $0.00 Strike: $88.66 | $0.00 |
DisclosureSEC source: 0001225208-25-005315 · doc4.xml · derivative · entry 6 Carter Pamela L · CIK 0001396958 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,107 shares Expires 2027-11-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 20, 2025 Filed May 20, 2025 15:38 UTC |
Carter Pamela LDirector
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 2,801 | $0.00 Strike: $107.52 | $0.00 |
DisclosureSEC source: 0001225208-25-005315 · doc4.xml · derivative · entry 5 Carter Pamela L · CIK 0001396958 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,801 shares Expires 2028-11-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 20, 2025 Filed May 20, 2025 15:38 UTC |
Carter Pamela LDirector
|
SaleCommon Stock | 2,806 | $242.23 | $679,706.92 |
DisclosureSEC source: 0001225208-25-005315 · doc4.xml · nonDerivative · entry 4 Carter Pamela L · CIK 0001396958 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,242 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $242.1595 - $242.5500, inclusive. The reporting person undertakes to provide to Broadridge Financial Solutions, Inc., any shareholder of Broadridge Financial Solutions, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (1) to this Form 4. Read SEC document |
| May 20, 2025 Filed May 20, 2025 15:38 UTC |
Carter Pamela LDirector
|
SaleCommon Stock | 2,023 | $242.23 | $490,038.17 |
DisclosureSEC source: 0001225208-25-005315 · doc4.xml · nonDerivative · entry 3 Carter Pamela L · CIK 0001396958 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,048 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $242.1595 - $242.5500, inclusive. The reporting person undertakes to provide to Broadridge Financial Solutions, Inc., any shareholder of Broadridge Financial Solutions, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (1) to this Form 4. Read SEC document |
| May 20, 2025 Filed May 20, 2025 15:38 UTC |
Carter Pamela LDirector
|
Exercise / conversionCommon Stock | 2,801 | $107.52 | $301,163.52 |
DisclosureSEC source: 0001225208-25-005315 · doc4.xml · nonDerivative · entry 2 Carter Pamela L · CIK 0001396958 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,071 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 20, 2025 Filed May 20, 2025 15:38 UTC |
Carter Pamela LDirector
|
Exercise / conversionCommon Stock | 4,107 | $88.66 | $364,126.62 |
DisclosureSEC source: 0001225208-25-005315 · doc4.xml · nonDerivative · entry 1 Carter Pamela L · CIK 0001396958 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,270 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 15, 2025 Filed May 16, 2025 19:37 UTC |
Jarkowski Hope M.Chief Legal Officer
|
SaleCommon Stock | 1,069 | $240.99 | $257,615.00 |
DisclosureSEC source: 0001225208-25-005217 · doc4.xml · nonDerivative · entry 1 Jarkowski Hope M. · CIK 0002024023 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1.25 F1 · shares: Consists of shares vested from sign-on time-based restricted stock unit award granted in consideration of awards she forfeited upon her departure from her former employer. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $240.86 - $241.00, inclusive. The reporting person undertakes to provide to Broadridge Financial Solutions, Inc., any shareholder of Broadridge Financial Solutions, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4. Read SEC document |
| May 13, 2025 Filed May 14, 2025 14:32 UTC |
Carey Thomas PCorporate VP
|
SaleCommon Stock | 3,607 | $237.26 | $855,797.54 |
DisclosureSEC source: 0001225208-25-005065 · doc4.xml · nonDerivative · entry 1 Carey Thomas P · CIK 0001731499 · Corporate VP 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,077 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $237.01 - $237.53, inclusive. The reporting person undertakes to provide to Broadridge Financial Solutions, Inc., any shareholder of Broadridge Financial Solutions, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (1) to this Form 4. Read SEC document |
| May 07, 2025 Filed May 7, 2025 20:27 UTC |
Jarkowski Hope M.Chief Legal Officer
|
SaleCommon Stock | 1,068 | $235.23 | $251,220.30 |
DisclosureSEC source: 0001225208-25-004826 · doc4.xml · nonDerivative · entry 1 Jarkowski Hope M. · CIK 0002024023 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,070.25 F1 · shares: Consists of shares vested from sign-on time-based restricted stock unit award granted in consideration of awards she forfeited upon her departure from her former employer. Read SEC document |
| May 07, 2025 Filed May 7, 2025 20:27 UTC |
Stingi Richard JohnCorporate VP and CHRO
|
SaleCommon Stock | 800 | $234.81 | $187,848.00 |
DisclosureSEC source: 0001225208-25-004827 · doc4.xml · nonDerivative · entry 1 Stingi Richard John · CIK 0001846577 · Corporate VP and CHRO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,508.799 Read SEC document |
| April 07, 2025 Filed Apr 8, 2025 16:52 UTC |
Carey Thomas PCorporate VP
|
Tax withholdingCommon Stock | 2,462 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-25-004154 · doc4.xml · nonDerivative · entry 1 Carey Thomas P · CIK 0001731499 · Corporate VP 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,684 Read SEC document |
| April 03, 2025 Filed Apr 7, 2025 15:52 UTC |
Duelks Robert NDirector
|
GrantCommon Stock | 74 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-25-004141 · doc4.xml · nonDerivative · entry 1 Duelks Robert N · CIK 0001477044 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,358 F1 · shares: The reported transaction reflects the award of additional Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the payment of Broadridge's regular quarterly dividend on the common stock underlying the Deferred Stock Units previously issued. This amount represents a like number of shares of Broadridge common stock. The Deferred Stock Units vest in full upon grant and will settle in shares of Broadridge common stock upon the director's separation from service with Broadridge. F2 · balance_after: Registrant transferred 6,226 shares of common stock owned directly to the Robert N. Duelks 2007 Revocable Trust. Read SEC document |
| April 03, 2025 Filed Apr 7, 2025 15:52 UTC |
FLOWERS MELVIN LDirector
|
GrantCommon Stock | 7 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-25-004136 · doc4.xml · nonDerivative · entry 1 FLOWERS MELVIN L · CIK 0001196490 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,173 F1 · shares: The reported transaction reflects the award of additional Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the payment of Broadridge's regular quarterly dividend on the common stock underlying the Deferred Stock Units previously issued. This amount represents a like number of shares of Broadridge common stock. The Deferred Stock Units vest in full upon grant and will settle in shares of Broadridge common stock upon the director's separation from service with Broadridge. Read SEC document |
| April 03, 2025 Filed Apr 7, 2025 15:52 UTC |
keller brettDirector
|
GrantCommon Stock | 13 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-25-004137 · doc4.xml · nonDerivative · entry 2 keller brett · CIK 0001214608 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,710 F2 · shares: The reported transaction reflects the award of additional Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the payment of Broadridge's regular quarterly dividend on the common stock underlying the Deferred Stock Units previously issued in lieu of cash compensation under the Director Deferred Compensation Program (the "DCUs"). This amount represents a like number of shares of Broadridge common stock. The DCUs vest in full upon grant and will settle in shares of Broadridge common stock commencing with the director's separation from service with Broadridge. Read SEC document |
| April 03, 2025 Filed Apr 7, 2025 15:52 UTC |
keller brettDirector
|
GrantCommon Stock | 30 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-25-004137 · doc4.xml · nonDerivative · entry 1 keller brett · CIK 0001214608 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,697 F1 · shares: The reported transaction reflects the award of additional Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the payment of Broadridge's regular quarterly dividend on the common stock underlying the Deferred Stock Units previously issued. This amount represents a like number of shares of Broadridge common stock. The Deferred Stock Units vest in full upon grant and will settle in shares of Broadridge common stock upon the director's separation from service with Broadridge. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.